560 top medical experts on Nasopharyngeal Carcinoma across 37 countries and 22 U.S. states, including 401 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Nasopharyngeal Carcinoma: A carcinoma that originates in the epithelium of the nasopharynx and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and papillary adenocarcinoma. It is most prevalent in Southeast Asian populations and is associated with epstein-barr virus infections. Somatic mutations associated with this cancer have been identified in npcr, BAP1, ubap1, erbb2, erbb3, MLL2, PIK3CA, kras, nras, and arid1A genes.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Nasopharyngeal Neoplasms (3,690), Carcinoma (3,648).
  4. Clinical Trials ClinicalTrials.gov : at least 569 including 41 Active, 157 Completed, 141 Recruiting




    Computing Expert Listing ...